- Home
- CLW vs LXEO Comparison
CLW vs LXEO Comparison
Compare CLW & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLW
- LXEO
- Stock Information
- Founded
- CLW 2005
- LXEO 2017
- Country
- CLW United States
- LXEO United States
- Employees
- CLW N/A
- LXEO N/A
- Industry
- CLW Paper
- LXEO
- Sector
- CLW Basic Materials
- LXEO
- Exchange
- CLW Nasdaq
- LXEO Nasdaq
- Market Cap
- CLW 338.8M
- LXEO 290.5M
- IPO Year
- CLW N/A
- LXEO 2023
- Fundamental
- Price
- CLW $17.32
- LXEO $9.89
- Analyst Decision
- CLW Strong Buy
- LXEO Strong Buy
- Analyst Count
- CLW 2
- LXEO 8
- Target Price
- CLW $30.00
- LXEO $18.13
- AVG Volume (30 Days)
- CLW 212.6K
- LXEO 1.5M
- Earning Date
- CLW 10-28-2025
- LXEO 11-14-2025
- Dividend Yield
- CLW N/A
- LXEO N/A
- EPS Growth
- CLW 875.72
- LXEO N/A
- EPS
- CLW 8.63
- LXEO N/A
- Revenue
- CLW $1,556,100,000.00
- LXEO N/A
- Revenue This Year
- CLW $12.53
- LXEO N/A
- Revenue Next Year
- CLW $1.41
- LXEO N/A
- P/E Ratio
- CLW $2.05
- LXEO N/A
- Revenue Growth
- CLW 23.00
- LXEO N/A
- 52 Week Low
- CLW $16.53
- LXEO $1.45
- 52 Week High
- CLW $33.57
- LXEO $11.72
- Technical
- Relative Strength Index (RSI)
- CLW 26.65
- LXEO 71.58
- Support Level
- CLW $16.53
- LXEO $8.65
- Resistance Level
- CLW $20.28
- LXEO $10.38
- Average True Range (ATR)
- CLW 0.79
- LXEO 0.65
- MACD
- CLW -0.10
- LXEO 0.01
- Stochastic Oscillator
- CLW 20.93
- LXEO 80.24
About CLW Clearwater Paper Corporation
Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.